1. Home
  2. SCKT vs PCSA Comparison

SCKT vs PCSA Comparison

Compare SCKT & PCSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Socket Mobile Inc.

SCKT

Socket Mobile Inc.

N/A

Current Price

$0.94

Market Cap

7.1M

Sector

Technology

ML Signal

N/A

Logo Processa Pharmaceuticals Inc.

PCSA

Processa Pharmaceuticals Inc.

N/A

Current Price

$2.80

Market Cap

8.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCKT
PCSA
Founded
1992
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
8.0M
IPO Year
1996
2012

Fundamental Metrics

Financial Performance
Metric
SCKT
PCSA
Price
$0.94
$2.80
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
23.3K
34.1K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.36
EPS
N/A
N/A
Revenue
$18,762,520.00
$5,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.15
N/A
52 Week Low
$0.82
$0.11
52 Week High
$1.36
$8.88

Technical Indicators

Market Signals
Indicator
SCKT
PCSA
Relative Strength Index (RSI) 47.18 57.48
Support Level $0.89 $0.21
Resistance Level $1.07 $3.80
Average True Range (ATR) 0.08 0.28
MACD 0.00 0.10
Stochastic Oscillator 36.11 76.92

Price Performance

Historical Comparison
SCKT
PCSA

About SCKT Socket Mobile Inc.

Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.

About PCSA Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).

Share on Social Networks: